BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181
15 results:

  • 1. CSNK1D-mediated phosphorylation of hnrnpa2b1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
    Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
    Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identifying intragenic functional modules of genomic variations associated with cancer phenotypes by learning representation of association networks.
    Kim M; Huffman JE; Justice A; Goethert I; Agasthya G; ; Danciu I
    BMC Med Genomics; 2022 Jul; 15(1):151. PubMed ID: 35794577
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies.
    Perez-Cornago A; Dunneram Y; Watts EL; Key TJ; Travis RC
    BMC Med; 2022 May; 20(1):143. PubMed ID: 35509091
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.
    Blayney DW; Mohanlal R; Adamchuk H; Kirtbaya DV; Chen M; Du L; Ogenstad S; Ginn G; Huang L; Zhang Q
    JAMA Netw Open; 2022 Jan; 5(1):e2145446. PubMed ID: 35084480
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Identification and validation of hub genes in prostate cancer progression based on weighted gene co-expression network analysis].
    Zhang H; Chen N; Wang X; Gao B; Ling M; Chen G; Wu Z; Li Y; Zhong W; Pan B
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1631-1640. PubMed ID: 34916188
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
    Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
    Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characterization of the m6A-Associated Tumor Immune Microenvironment in prostate cancer to Aid Immunotherapy.
    Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G
    Front Immunol; 2021; 12():735170. PubMed ID: 34531875
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Systematic Investigation of mRNA
    Jiang M; Lu Y; Duan D; Wang H; Man G; Kang C; Abulimiti K; Li Y
    Dis Markers; 2020; 2020():8833438. PubMed ID: 33273988
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis.
    Cheng Y; Li L; Qin Z; Li X; Qi F
    J Cell Mol Med; 2020 Jul; 24(14):8006-8017. PubMed ID: 32485038
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B
    Tong A; Lemberskiy G; Huang C; Shanbhogue K; Feiweier T; Rosenkrantz AB
    J Magn Reson Imaging; 2019 Nov; 50(5):1614-1619. PubMed ID: 30990941
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification and characterization of novel fusion genes in prostate cancer by targeted RNA capture and next-generation sequencing.
    Yang J; Chen Y; Lu J; Wang X; Wang L; Liang J; Sun ZS
    Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1166-1172. PubMed ID: 30307468
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TWIST1-WDR5-
    Malek R; Gajula RP; Williams RD; Nghiem B; Simons BW; Nugent K; Wang H; Taparra K; Lemtiri-Chlieh G; Yoon AR; True L; An SS; DeWeese TL; Ross AE; Schaeffer EM; Pienta KJ; Hurley PJ; Morrissey C; Tran PT
    Cancer Res; 2017 Jun; 77(12):3181-3193. PubMed ID: 28484075
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The RNA-binding protein hnrnpa2 regulates β-catenin protein expression and is overexpressed in prostate cancer.
    Stockley J; Villasevil ME; Nixon C; Ahmad I; Leung HY; Rajan P
    RNA Biol; 2014; 11(6):755-65. PubMed ID: 24823909
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells.
    Torosyan Y; Dobi A; Glasman M; Mezhevaya K; Naga S; Huang W; Paweletz C; Leighton X; Pollard HB; Srivastava M
    Oncogene; 2010 Apr; 29(17):2457-66. PubMed ID: 20190808
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.